ArticleScientific reports2025
Impact of two nano-pesticide formulations in combating the two-spotted spider mite, Tetranychus urticae Koch, and their residues in cucumber fruits, Cucumis sativus L.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nano-pesticides aim to improve the efficacy and safety of conventional pesticides, but as they are still in the early stages of development, data about their environmental fate is insufficient. Therefore, the aim of this study is to compare between the conventional and nano-formulations of chlorfenapyr (CF) and emamectin benzoate (EB), by using chitosan nanoparticles as carriers and evaluating it against the two-spotted spider mite, Tetranychus urticae Koch. The loading capacities were 52.2 and 41.7%, respectively. The nanoparticles sizes of both chlorfenapyr (CF NPs) and emamectin benzoate (EB NPs) were 99.86 and 78.82 nm, respectively. The LC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.